20INDIA

Conference dateSeptember 19th-20th, 2020

Course DirectorsProf. Dr. Thomas F. Lüscher,

London and Zurich

Dr. C. Venkata S. Ram,Hyderabad, Dallas and Sydney

VenueVirtual Meet

In collabration with

It is a pleasure to announce the 2nd Indo-European Cardiology Update to be held on September 19th - 20th, 2020. Based on the tremendous success and wide acclaim for the Cardiology Update 2019 in Mumbai, the

organizers have assembled a truly spectacular scientific program for this year. The joint Indo-European collaboration in the field of cardiology from prevention to management of coronary disease and heart

failure is an important avenue to decrease the chronic disease burden in India.

The proposed scientific agenda includes the latest trends in hypertension, Lipid disorders and diabetes based on evidence and the most recent guidelines which are of paramount importance to the physicians

in clinical practice. The course will further include state-of-art presentations by eminent Indian and European faculty known for their clinical expertise in the most common cardiac conditions.

We are confident that the Indo-European Cardiology Update 2020 will be yet another milestone in professional education and in the annals of preventive cardiology. The attendees will gain additional

clinical tools in the early identification of cardiovascular risk factors and in the management of cardiovascular disease in the community.

Best wishes and kind regards,

20INDIA

Prof. Dr. Thomas F. LüscherLondon and ZurichCourse Director

Dr. C. Venkata S. RamHyderabad, Dallas and Sydney Course Director

INDO-EUROPEAN CARDIOLOGY UPDATESeptember 19th-20th, 2020

I N V I T A T I O N

DAY - 1 Saturday, September 19th, 2020

A G E N D A

Welcome Address Session: London 12:30 pm, Zurich 1:30 pm & India: 5:00 pm

Session 1: Prevention Chairs; Ulrich Laufs, Leipzig, Germany & P. P. Mohanan, Thrissur, India

Session 2: Cardiovascular Disease; An Overview Chairs: Bernard Gersh, Rochester, USA & C. K. Ponde, Mumai, India

Session End Time: London 3:45 pm, Zurich 4:45 pm & India 8:15 pm

5:00 pm Welcome, Introduction5:10 pm Greetings from the Zurich Heart House

ISTC. Venkata S. Ram, Hyderabad, India

Thomas F. Lüscher, London & Zurich

Thomas F. Lüscher, London & Zurich

C. Venkata S. Ram, Hyderabad, India

Ulrich Laufs, Leipzig, Germany

J. P. S. Sawhney, New Delhi, India

Bernard Gersh, Rochester, USA

Ajit Mullasari, Chennai, India

P. P. Mohanan, Thrissur, India

5:20 pm A personalized approach towards prevention5:40 pm Hypertension 2020: Salient Features6:00 pm Dyslipidaemia: Treatment targets and novel strategies (new ESC Guidelines)6:20 pm Optimal pharmacotherapy to achieve lipid target levels in clinical practice

6:40 pm Panel discussion, Q and A

7:15 pm Management of chronic coronary syndromes after the ISCHEMIA trial: Do we need to change the Guidelines7:35 pm Dual antiplatelet therapy: Scientific evidence and a practical guide7:55 pm What is the current status and evidence for aspirin usage in the prevention of vascular disease

8:15 pm Panel discussion, Q and A Audience Participation

Audience Participation

Welcome Address Session: London 12:30 pm, Zurich 1:30 pm & India: 5:00 pm

Session End Time: London 3:50 pm, Zurich 4:50 pm & India 8:20 pm

IST

DAY - 2 Sunday, September 20th, 2020

A G E N D A

Audience Participation

Session 3: Cardiovascular Disease; An Overview Chairs: Jamshed Dalal, Mumbai, India & Lars Soendergaard, Copenhagen, Denmark

Session 4: Cardio-metabolic Disorders, Heart Failure Chairs: Yash Lokhandawala, Mumbai, India & Martin Cowie, London, UK

Nagaraj Desai, Bangalore, India

Ulrich Laufs, Leipzig, Germany

Rajeev Agarwala, Meerut, India

Jamshed Dalal, Mumbai, India

Thomas F. Lüscher, London & Zurich

C. Venkata S. Ram, Hyderabad, India

Yash Lokhandwala, Mumbai, India

Lars Soendergaard, Copenhagen, Denmark

Rishi Sethi, Lucknow, India

6:30 pm Importance of additional cardiovascular risk reduction in diabetes: The role of statins6:50 pm Heart failure and diabetes: Mechanisms and new treatment options (ESC Guidelines)7:10 pm Adjunctive and complementary therapeutic approaches to decrease the overall cardiovascular disease risk in the community7:30 pm Rationale behind combination lipid lowering therapy in high risk patients

7:50 pm Panel discussion, Q and A Audience Participation

8:20 pm Concluding remarks and way forward

5:00 pm Important and interesting cardiac arrhythmias in clinical practice: A tutorial5:20 pm Management of Aortic valve disease in 2020

5:40 pm Non-invasive techniques to detect coronary artery disease

6:00 Panel discussion, Q and A